<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Iranian Chemical Science and Technologies Association</PublisherName>
				<JournalTitle>International Journal of New Chemistry</JournalTitle>
				<Issn>2645-7237</Issn>
				<Volume>12</Volume>
				<Issue>5</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>04</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Superoxide Dismutase Inhibitors as Cancer Chemopreventive Agents: A New Survey</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1029</FirstPage>
			<LastPage>1035</LastPage>
			<ELocationID EIdType="pii">722918</ELocationID>
			
<ELocationID EIdType="doi">10.22034/ijnc.2025.722918</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Mahboubi-Rabbani</LastName>
<Affiliation>Department of Pharmaceutical Chemistry, School of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Atefeh</FirstName>
					<LastName>Jozian</LastName>
<Affiliation>Department of Pharmaceutical Chemistry, School of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Gita</FirstName>
					<LastName>Faraji</LastName>
<Affiliation>Department of Pharmaceutical Chemistry, School of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Sana</FirstName>
					<LastName>Khatami</LastName>
<Affiliation>Department of Pharmaceutical Chemistry, School of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Kiana</FirstName>
					<LastName>Ravanshad</LastName>
<Affiliation>Department of Pharmaceutical Chemistry, School of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Bayanati</LastName>
<Affiliation>Department of Food Technology Research, National Nutrition, and Food Technology Research Institute/Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>04</Month>
					<Day>20</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span style=&quot;font-size: 11.0pt; line-height: 150%; font-weight: normal;&quot;&gt;Reactive oxygen species (ROS) are important factors to carcinogenesis, serving as both initiators and promoters of tumor growth. Superoxide dismutases (SODs), a kind of antioxidant enzyme, regulate ROS levels by converting superoxide anions into hydrogen peroxide. While SODs have generally served protective roles, current research has revealed a paradoxical involvement in cancer cell survival and resistance to treatment. This review presents a complete overview of current understanding about SOD inhibitors and their potential as cancer chemopreventive medicines, with a focus on processes, molecular targets, and treatment methods. Eighteen references are mentioned to lay a solid basis for future study in this promising field of cancer.&lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Reactive Oxygen Species (ROS)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Superoxide Dismutases</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Protective Roles</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cancer cell survival</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cancer Chemopreventive</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijnc.ir/article_722918_bd5b69baeb0bee8558d7f6e078708603.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
